HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

saxagliptin

inhibits Dipeptidyl Peptidase-4
Also Known As:
3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate; BMS 477118; BMS-477118; BMS477118; Onglyza; (1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl) acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile hydrate
Networked: 425 relevant articles (46 outcomes, 162 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Hirshberg, Boaz: 28 articles (01/2019 - 11/2011)
2. Raz, Itamar: 25 articles (11/2021 - 10/2010)
3. Bhatt, Deepak L: 22 articles (11/2021 - 11/2011)
4. Scirica, Benjamin M: 22 articles (11/2021 - 11/2011)
5. Mosenzon, Ofri: 21 articles (11/2021 - 10/2013)
6. Iqbal, Nayyar: 18 articles (01/2022 - 10/2013)
7. Braunwald, Eugene: 18 articles (11/2021 - 11/2011)
8. Frederich, Robert: 13 articles (08/2015 - 05/2010)
9. Cahn, Avivit: 11 articles (11/2021 - 06/2015)
10. Johnsson, Eva: 11 articles (01/2020 - 01/2018)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Hypoglycemia (Reactive Hypoglycemia)
3. Body Weight (Weight, Body)
4. Diabetes Mellitus
5. Inflammation (Inflammations)

Related Drugs and Biologics

1. Metformin (Glucophage)
2. dapagliflozin
3. Glucose (Dextrose)
4. Sitagliptin Phosphate (Januvia)
5. alogliptin
6. glimepiride (Amarel)
7. saxagliptin
8. Insulin (Novolin)
9. 2,4-thiazolidinedione (thiazolidinedione)
10. Lipids

Related Therapies and Procedures

1. Glycemic Control
2. Therapeutics
3. Renal Dialysis (Hemodialysis)
4. Aftercare (After-Treatment)
5. Cardiac Resynchronization Therapy